[google-translator]

ACE for metastatic IBC

Alternative Drug Names: Atezolizumab is also known as Tecentriq. Cobimetinib is also known as Cotellic. Eribulin is also called Halavan. Purpose of Trial: This is a trial of a novel combination for chemotherapy-resistant metastatic IBC. The purpose is to determine the...

Dual HER2 + Abraxane

Alternative Drug Names: Nab-Paclitaxel (Abraxane brand in the US), Trastuzumab (Herceptin is the brand in the US and abroad), Pertuzumab (Perjeta brand in the US and abroad) Purpose of Trial: The purpose of this phase 2 study is to evaluate the effectiveness of the 3...

Ruxolitinib + Paclitaxel IBC

Alternative Drug Names: Ruxolitinib (Jakafi brand in the US) was previously also known as INCB018242. Purpose of Trial: The purpose of this phase 1/2 study is 2-fold. In the first part of the study in metastatic breast cancer patients, the goal is to determine a safe...

Nintedanib IBC

Alternative Drug Names: Nintedanib was called BIBF 1120 (Ofev brand in the US) Purpose of Trial: The purpose of this phase 2 study is to evaluate the safety and efficacy of Nintedanib in the setting of metastatic IBC. Nintedanib is FDA approved outside of oncology,...

MK-3475 (Keytruda) IBC

Alternative Drug Names: MK-3475 is now Pembrolizumab (Keytruda brand in the US) Purpose of Trial: This is a phase 2 trial to determine the safety and efficacy of MK-3475 as a single drug in the setting of prior chemotherapy for metastatic IBC. MK-3475 has been FDA...
Translate »

Pin It on Pinterest

X
X